Your browser doesn't support javascript.
loading
Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy.
Soleimani, Milad; Somma, Alexander; Kaoud, Tamer; Goyal, Ria; Bustamante, Jorge; Wylie, Dennis C; Holay, Nisha; Looney, Agnieszka; Giri, Uma; Triplett, Todd; Dalby, Kevin; Kowalski, Jeanne; Eckhardt, S Gail; Van Den Berg, Carla.
Afiliação
  • Soleimani M; Interdisciplinary Life Sciences Graduate Programs, The University of Texas at Austin, Austin, Texas.
  • Somma A; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Kaoud T; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Goyal R; Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy, The University of Texas at Austin, Austin, Texas.
  • Bustamante J; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Wylie DC; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Holay N; Center for Biomedical Research Support, The University of Texas at Austin, Austin, Texas.
  • Looney A; Interdisciplinary Life Sciences Graduate Programs, The University of Texas at Austin, Austin, Texas.
  • Giri U; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Triplett T; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Dalby K; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Kowalski J; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
  • Eckhardt SG; Interdisciplinary Life Sciences Graduate Programs, The University of Texas at Austin, Austin, Texas.
  • Van Den Berg C; Livestrong Cancer Institutes, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, Texas.
Mol Cancer Ther ; 21(10): 1547-1560, 2022 10 07.
Article em En | MEDLINE | ID: mdl-35977156
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article